Harnessing Bacterial Membrane Components for Tumor Vaccines: Strategies and Perspectives
Advanced Healthcare Materials · 2024
DOI: 10.1002/adhm.202401615 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, 2024. Verfasst von Zhenxin Bai und 8 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection & School for Radiological and Interdisciplinar…. Hauptthemen laut MEDLINE: Cancer Vaccines, Neoplasms. Die Arbeit wurde bisher 23-mal zitiert (Crossref) und nennt 172 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Natural Science Foundation of Anhui Province, Key Scientific Research Project of Colleges and Universities of Anhui Province of China.
Abstract (Originalsprache)
Tumor vaccines stand at the vanguard of tumor immunotherapy, demonstrating significant potential and promise in recent years. While tumor vaccines have achieved breakthroughs in the treatment of cancer, they still encounter numerous challenges, including improving the immunogenicity of vaccines and expanding the scope of vaccine application. As natural immune activators, bacterial components offer inherent advantages in tumor vaccines. Bacterial membrane components, with their safer profile, easy extraction, purification, and engineering, along with their diverse array of immune components, activate the immune system and improve tumor vaccine efficacy. This review systematically summarizes the mechanism of action and therapeutic effects of bacterial membranes and its derivatives (including bacterial membrane vesicles and hybrid membrane biomaterials) in tumor vaccines. Subsequently, the authors delve into the preparation and advantages of tumor vaccines based on bacterial membranes and hybrid membrane biomaterials. Following this, the immune effects of tumor vaccines based on bacterial outer membrane vesicles are elucidated, and their mechanisms are explained. Moreover, their advantages in tumor combination therapy are analyzed. Last, the challenges and trends in this field are discussed. This comprehensive analysis aims to offer a more informed reference and scientific foundation for the design and implementation of bacterial membrane‐based tumor vaccines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Radiation Medicine and Protection, School of Radiation Medicine and Protection & School for Radiological and Interdisciplinary Sciences (RAD-X), Collaborative Innovation Center of Radiation Medic…
- Teaching and Research Section of Nuclear Medicine, School of Basic Medical Sciences, Anhui Medical University, 81 Meishan Road, Hefei, Anhui, 230032, People's Republic of China.
- Jiangsu Provincial Key Laboratory of Infection and Immunity, Institutes of Biology and Medical Sciences, Soochow University, P.R. China.
ORCID-Profile: Pei Pei
Förderung
- National Natural Science Foundation of China
- Natural Science Foundation of Anhui Province
- Key Scientific Research Project of Colleges and Universities of Anhui Province of China
- National Undergraduate Training Program for Innovation and Entrepreneurship
- Gusu Leading Talent Program for Innovation and Entrepreneurship
- Priority Academic Program Development of Jiangsu Higher Education Institutions
Zitieren
APA
Bai, Z., Wang, X., Liang, T., Xu, G., Cai, J., Xu, W., Yang, K., Hu, L., & Pei, P. (2024). Harnessing Bacterial Membrane Components for Tumor Vaccines: Strategies and Perspectives. Advanced Healthcare Materials. https://doi.org/10.1002/adhm.202401615
Vancouver
Bai Z, Wang X, Liang T, Xu G, Cai J, Xu W, et al. Harnessing Bacterial Membrane Components for Tumor Vaccines: Strategies and Perspectives. Advanced Healthcare Materials. 2024. doi:10.1002/adhm.202401615
BibTeX
@article{Bai2024,
author = {Bai, Zhenxin and Wang, Xuanyu and Liang, Tianming and Xu, Guangyu and Cai, Jinzhou and Xu, Wei and Yang, Kai and Hu, Lin and Pei, Pei},
title = {Harnessing Bacterial Membrane Components for Tumor Vaccines: Strategies and Perspectives},
journal = {Advanced Healthcare Materials},
year = {2024},
doi = {10.1002/adhm.202401615}
}
EUVIMED